NM_000620.5:c.1664+144C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000620.5(NOS1):c.1664+144C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.336 in 950,458 control chromosomes in the GnomAD database, including 56,828 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 7001 hom., cov: 31)
Exomes 𝑓: 0.35 ( 49827 hom. )
Consequence
NOS1
NM_000620.5 intron
NM_000620.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.28
Publications
14 publications found
Genes affected
NOS1 (HGNC:7872): (nitric oxide synthase 1) The protein encoded by this gene belongs to the family of nitric oxide synthases, which synthesize nitric oxide from L-arginine. Nitric oxide is a reactive free radical, which acts as a biologic mediator in several processes, including neurotransmission, and antimicrobial and antitumoral activities. In the brain and peripheral nervous system, nitric oxide displays many properties of a neurotransmitter, and has been implicated in neurotoxicity associated with stroke and neurodegenerative diseases, neural regulation of smooth muscle, including peristalsis, and penile erection. This protein is ubiquitously expressed, with high level of expression in skeletal muscle. Multiple transcript variants that differ in the 5' UTR have been described for this gene but the full-length nature of these transcripts is not known. Additionally, alternatively spliced transcript variants encoding different isoforms (some testis-specific) have been found for this gene.[provided by RefSeq, Feb 2011]
NOS1 Gene-Disease associations (from GenCC):
- idiopathic achalasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.357 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NOS1 | NM_000620.5 | c.1664+144C>T | intron_variant | Intron 9 of 28 | ENST00000317775.11 | NP_000611.1 | ||
| NOS1 | NM_001204218.2 | c.1664+144C>T | intron_variant | Intron 9 of 29 | NP_001191147.1 | |||
| NOS1 | NM_001204213.2 | c.656+144C>T | intron_variant | Intron 8 of 27 | NP_001191142.1 | |||
| NOS1 | NM_001204214.2 | c.656+144C>T | intron_variant | Intron 8 of 27 | NP_001191143.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NOS1 | ENST00000317775.11 | c.1664+144C>T | intron_variant | Intron 9 of 28 | 1 | NM_000620.5 | ENSP00000320758.6 | |||
| NOS1 | ENST00000338101.8 | c.1664+144C>T | intron_variant | Intron 8 of 28 | 5 | ENSP00000337459.4 | ||||
| NOS1 | ENST00000618760.4 | c.1664+144C>T | intron_variant | Intron 9 of 29 | 5 | ENSP00000477999.1 |
Frequencies
GnomAD3 genomes AF: 0.279 AC: 42409AN: 151792Hom.: 7001 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
42409
AN:
151792
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.347 AC: 277154AN: 798548Hom.: 49827 AF XY: 0.348 AC XY: 140213AN XY: 403434 show subpopulations
GnomAD4 exome
AF:
AC:
277154
AN:
798548
Hom.:
AF XY:
AC XY:
140213
AN XY:
403434
show subpopulations
African (AFR)
AF:
AC:
2033
AN:
19248
American (AMR)
AF:
AC:
5088
AN:
22226
Ashkenazi Jewish (ASJ)
AF:
AC:
5274
AN:
14976
East Asian (EAS)
AF:
AC:
7760
AN:
33448
South Asian (SAS)
AF:
AC:
16563
AN:
49050
European-Finnish (FIN)
AF:
AC:
13745
AN:
37034
Middle Eastern (MID)
AF:
AC:
1016
AN:
2522
European-Non Finnish (NFE)
AF:
AC:
213380
AN:
583242
Other (OTH)
AF:
AC:
12295
AN:
36802
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
8491
16982
25472
33963
42454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5580
11160
16740
22320
27900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.279 AC: 42407AN: 151910Hom.: 7001 Cov.: 31 AF XY: 0.281 AC XY: 20879AN XY: 74218 show subpopulations
GnomAD4 genome
AF:
AC:
42407
AN:
151910
Hom.:
Cov.:
31
AF XY:
AC XY:
20879
AN XY:
74218
show subpopulations
African (AFR)
AF:
AC:
4576
AN:
41464
American (AMR)
AF:
AC:
3893
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1244
AN:
3464
East Asian (EAS)
AF:
AC:
1326
AN:
5126
South Asian (SAS)
AF:
AC:
1624
AN:
4806
European-Finnish (FIN)
AF:
AC:
4069
AN:
10546
Middle Eastern (MID)
AF:
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24487
AN:
67916
Other (OTH)
AF:
AC:
632
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1472
2944
4417
5889
7361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.